134.40 USD
↘ 0.09 (0.07%)PRE MARKET (AS OF 07:11 AM EDT)
Apogee Therapeutics, Inc. Common Stock
APGENASDAQ • USD
Market: OPEN
Shares of Apogee Therapeutics, Inc. Common Stock (APGE) are trading at $134.40. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, APGE is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 6, 2026.
Open?$134.63
High?$134.63
Low?$134.40
Prev. Close?$134.49
Volume?5
Avg. Volume?1.9M
VWAP?$134.40
Rel. Volume?0.00x
Bid / Ask
Bid?$115.38 × 100
Ask?$153.16 × 100
Spread?$37.78
Midpoint?$134.27
Valuation & Ratios
Market Cap?10.2B
Shares Out?61.9M
Float?57.3M
Float %?92.6%
P/E Ratio?N/A
P/B Ratio?8.10
EPS?-$3.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Employees
261
Market Cap
10.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-07-14
Address
221 CRESCENT ST.
WALTHAM, MA 02453
Phone: 650-394-5230
WALTHAM, MA 02453
Phone: 650-394-5230
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?76
Piotroski F-Score?0/9Weak
Altman Z-Score?160.68Safe
Confidence?52%Low
Short InterestElevated
Short % of Float?7.21%Elevated
Short Interest?4.1M
Days to Cover?2.4
Free Float57.3M
Avg Daily Volume1.7M
Settlement Date2026-07-15
Financial Health
Current Ratio?32.59Strong
Quick Ratio?32.59Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?8.10HIGH▾
Peers100
S&P23
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-32.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-21.9%WEAK▾
S&P7
ROA?-21.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-235373000
Enterprise Value?$9.7B
Fundamentals ratios updated end of day